1. Home
  2. GLND vs ANIX Comparison

GLND vs ANIX Comparison

Compare GLND & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GLND

Greenland Energy Company Common Stock

SELL

Current Price

$3.90

Market Cap

101.0M

Sector

Energy

ML Signal

SELL

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

SELL

Current Price

$2.66

Market Cap

114.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
GLND
ANIX
Founded
N/A
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.0M
114.0M
IPO Year
2026
2013

Fundamental Metrics

Financial Performance
Metric
GLND
ANIX
Price
$3.90
$2.66
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $9.75
AVG Volume (30 Days)
★ 25.6M
297.3K
Earning Date
11-18-2026
09-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 12.82
EPS
★ N/A
N/A
Revenue
N/A
★ $210,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.09
$2.32
52 Week High
$12.80
$5.46

Technical Indicators

Market Signals
Indicator
GLND
ANIX
Relative Strength Index (RSI) 58.64 36.52
Support Level $2.60 $2.62
Resistance Level $6.69 $3.09
Average True Range (ATR) 0.82 0.15
MACD -0.14 -0.00
Stochastic Oscillator 36.47 2.08

Price Performance

Historical Comparison
GLND
ANIX

About GLND Greenland Energy Company Common Stock

Greenland Energy Co is a Texas energy resources company focused on unlocking Greenland's vast hydrocarbon potential through the application of modern exploration technologies. It holds exclusive licenses to over 2-million acre area in the Jameson Land Basin, where its licenses cover the majority of the basin. The business model for the company is based on exploration and resource development in the frontier basins of Greenland. The company's primary focus is drilling the first wells on the project to conduct the necessary exploration, appraisal and evaluation.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: